Hospital Jerez Puerta Del Sur Grupo Hla S.A.

Jerez De La Frontera 5 trials 1 recruiting

5 Registered trials

1 Currently recruiting

Organisation

Hospital Jerez Puerta Del Sur Grupo Hla S.A.

Location

Jerez De La Frontera, Spain

Identifier

ORG-100046899

Address

Avenida De La Puerta Del Sur Sn, 11408, Spain

Departments

#93158005
#98358005: Oncology
Intensive Care medicine
Oncologia Medica
Urology

Clinical trials at this site (5)

Search interface

A PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III me… Recruiting

2025-521919-39-00 Resected stage IIB, IIC, or III melanoma requiring adju 3 2026-02-10
A Study to Evaluate ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Unresectable or Metastatic Melanoma Ended

2023-503288-40-00 Unresectable or Metastatic Melanoma 5 2024-01-26
A study of androgen deprivation therapy (ADT) plus apalutamide in patients with prostate cancer Ended

2023-506153-38-00 High-risk localized or locally advanced prostate cancer 5 2019-07-11
A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV … Ended

2022-502620-49-00 Resected Melanoma Stage III or Stage IV 2 2023-08-01
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN) Ended

2024-515813-17-00 Acute Respiratory Distress Syndrome (ARDS) 5